首页> 外文期刊>Oncology Research >NlicroRNA-520b Functions as a Tumor Suppressor in Colorectal Cancer by Inhibiting Defective in Cullin Neddylation 1 Domain Containing 1 (DCUN1D1)
【24h】

NlicroRNA-520b Functions as a Tumor Suppressor in Colorectal Cancer by Inhibiting Defective in Cullin Neddylation 1 Domain Containing 1 (DCUN1D1)

机译:Nlicrorna-520B通过抑制含有1的Cullin Neddylation1结构域的缺陷来用作结肠直肠癌中的肿瘤抑制剂(DCUN1D1)

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRs). a class of small noncoding RNAs, are important regulators for gene expression through directly binding to the 3'-untranslated region (3'-UTR) of their target mRNA. Recently, downregulation of miR-520b has been observed in several common human cancers. however, the exact role of miR-520b in colorectal cancer (CRC) has not previously been studied. In this study, our data showed that miR-520b was significantly downregulated in CRC and cell lines when compared with adjacent normal tissues and a normal intestinal epithelial cell line. Low expression of miR-520b was notably associated with the malignant progress and a shorter survival time for CRC patients. Restoration of miR-520b inhibited cell proliferation, migration. invasion, and epithelial-mesenchymal transition (EMT) in CRC cells. Defective in cullin neddylation 1 domain containing 1 (DCUN1D1) was then identified as a novel target gene of miR-520b in CRC cells. The expression of DCUN1D1 was significantly increased in CRC, with a negative correlation to miR-520b expression in CRC tissues. Moreover, a high expression of DCUN1D1 was significantly associated with the malignant progress and a poor prognosis for CRC patients. Furthermore, overexpression of DCUN1D1 rescued the miR-520b-mediated malignant phenotypes and EMT in CRC cells. The data demonstrate that miR-520b functions as a tumor suppressor in CRC through targeting DCUN1D1, suggesting that miR-520b may become a potential therapeutic target for the treatment of CRC.
机译:microRNA(MIRS)。一类小的非致rNA,是基因表达的重要调节因子,通过直接结合其靶mRNA的3'-未翻译区域(3'-UTR)。最近,在几种常见的人类癌症中观察到miR-520b的下调。然而,先前尚未研究miR-520b在结肠直肠癌(CRC)中的确切作用。在该研究中,我们的数据显示,与相邻的正常组织和正常肠上皮细胞系相比,MIR-520B在CRC和细胞系中显着下调。 miR-520b的低表达明显与恶性进展和CRC患者的较短生存时间相关。恢复miR-520b抑制细胞增殖,迁移。侵袭和上皮 - 间充质转换(EMT)在CRC细胞中。然后在CrC细胞中鉴定含有1(DCUN1D1)的Cullin Neddylation1结构域(DCUN1D1)的结构域。 CRC中DCUN1D1的表达显着增加,与CRC组织中的miR-520b表达具有负相关。此外,DCUN1D1的高表达与CRC患者的恶性进展显着相关,并且对CRC患者的预后差。此外,DCUN1D1的过度表达拯救了CRC细胞中的miR-520b介导的恶性表型和EMT。数据证明MIR-520B通过靶向DCUN1D1作为CRC中的肿瘤抑制剂用作肿瘤抑制剂,表明MIR-520B可以成为治疗CRC的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号